FI105812B - Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI105812B
FI105812B FI931667A FI931667A FI105812B FI 105812 B FI105812 B FI 105812B FI 931667 A FI931667 A FI 931667A FI 931667 A FI931667 A FI 931667A FI 105812 B FI105812 B FI 105812B
Authority
FI
Finland
Prior art keywords
alkyl
indole
aryl
ylmethyl
hydrogen
Prior art date
Application number
FI931667A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI931667A (fi
FI931667A0 (fi
Inventor
Martin James Wythes
John Eugene Macor
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24393510&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI105812(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of FI931667A publication Critical patent/FI931667A/fi
Publication of FI931667A0 publication Critical patent/FI931667A0/fi
Application granted granted Critical
Publication of FI105812B publication Critical patent/FI105812B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Lasers (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI931667A 1990-10-15 1993-04-14 Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi FI105812B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US59792890A 1990-10-15 1990-10-15
US59792890 1990-10-15
PCT/US1991/007194 WO1992006973A1 (fr) 1990-10-15 1991-10-08 Derives d'indole
US9107194 1991-10-08

Publications (3)

Publication Number Publication Date
FI931667A FI931667A (fi) 1993-04-14
FI931667A0 FI931667A0 (fi) 1993-04-14
FI105812B true FI105812B (fi) 2000-10-13

Family

ID=24393510

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931667A FI105812B (fi) 1990-10-15 1993-04-14 Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi

Country Status (33)

Country Link
EP (1) EP0592438B1 (fr)
JP (2) JP2575272B2 (fr)
KR (1) KR0179053B1 (fr)
CN (1) CN1039322C (fr)
AT (1) ATE157361T1 (fr)
AU (1) AU651637B2 (fr)
BG (1) BG61975B1 (fr)
BR (2) BR9106978A (fr)
CA (1) CA2091562C (fr)
DE (3) DE9190141U1 (fr)
DK (1) DK0592438T5 (fr)
EG (1) EG20224A (fr)
ES (1) ES2104733T3 (fr)
FI (1) FI105812B (fr)
GR (1) GR3025087T3 (fr)
HU (2) HU225055B1 (fr)
IE (1) IE913555A1 (fr)
IL (3) IL115117A (fr)
LU (1) LU90902I2 (fr)
MX (1) MX9101606A (fr)
MY (1) MY111683A (fr)
NL (1) NL300070I2 (fr)
NO (3) NO305121B1 (fr)
NZ (2) NZ270675A (fr)
OA (1) OA09874A (fr)
PL (3) PL168919B1 (fr)
PT (1) PT99218B (fr)
RO (1) RO111767B1 (fr)
RU (1) RU2095360C1 (fr)
SG (1) SG54270A1 (fr)
WO (1) WO1992006973A1 (fr)
YU (1) YU48088B (fr)
ZA (1) ZA918156B (fr)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
BR9206810A (pt) * 1991-11-25 1995-10-31 Pfizer Derivados de indol
TW288010B (fr) * 1992-03-05 1996-10-11 Pfizer
CZ281763B6 (cs) * 1992-04-07 1997-01-15 Pfizer Inc. Indolové deriváty představující 5-HT1 agonisty, způsob jejich přípravy, farmaceutické prostředky obsahující tyto látky, jejich použití a meziprodukty postupu přípravy
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
SK278182B6 (en) * 1992-04-10 1996-03-06 Pfizer Acylaminoindole derivatives as 5-ht1 agonists, method of their preparation and pharmaceutical compositions containing these matters their use and semifinished products of preparation proces
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
TW251284B (fr) * 1992-11-02 1995-07-11 Pfizer
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
BR9406481A (pt) * 1993-04-22 1996-01-09 Pfizer Res & Dev Derivados de indol como agonistas do tipo 5-HT1 para utilização na enxaqueca
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.
ES2070772B1 (es) * 1993-08-09 1996-02-16 Pfizer Derivados de acilaminoindol
DK0716649T3 (da) * 1993-08-31 1999-02-08 Pfizer 5-Arylindolderivater
AU3162695A (en) * 1994-08-03 1996-03-04 Asta Medica Aktiengesellschaft Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
AU726560B2 (en) * 1994-10-12 2000-11-09 Pfizer Research And Development Company, N.V./S.A. Use of indole derivatives for the treatment of various diseases
ATE224388T1 (de) * 1994-10-12 2002-10-15 Pfizer Res & Dev Indolderivate zur behandlung von migräne
GB9420529D0 (en) * 1994-10-12 1994-11-30 Pfizer Ltd Indoles
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
CZ288897A3 (cs) * 1995-03-20 1998-02-18 Eli Lilly And Company V poloze 5-substituovaný 3-(1,2,3,6-tetrahydropyridin-4-yl)indol a 3-(piperidin-4-yl)indol a farmaceutický prostředek, který je obsahuje
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
GB9714383D0 (en) * 1997-07-08 1997-09-10 Pfizer Ltd Improved process
WO1999053956A1 (fr) * 1998-04-16 1999-10-28 Yamanouchi Pharmaceutical Co., Ltd. Remedes contre l'obesite
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
JP2000336074A (ja) 1999-03-24 2000-12-05 Sumitomo Chem Co Ltd [2−(アリールスルホニル)エテニル]ベンゼン誘導体の製造方法
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
KR20020035857A (ko) * 1999-08-26 2002-05-15 후지야마 아키라 인돌 유도체 또는 그의 염의 제조방법
GB9923314D0 (en) * 1999-10-01 1999-12-08 Pfizer Ltd Acylation process
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
GB0031094D0 (en) * 2000-12-20 2001-01-31 Pfizer Ltd New Process
US20030166704A1 (en) 2000-12-20 2003-09-04 Pfizer Inc. New process
US8329734B2 (en) 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
TR201900509T4 (tr) 2001-08-15 2019-02-21 Pharmacia & Upjohn Co Llc Bir ilaç olarak kullanılmaya yönelik n-[2-(dietilamino)etil]-5-[(5-floro-1,2-dihidro-2-okso-3h-indol-3-iliden)metil]-2,4-dimetil-1h-pirol-3-karboksamidin l-malik asit tuzunu içeren bir kristal.
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
WO2004112723A2 (fr) 2003-06-20 2004-12-29 Ronald Aung-Din Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
EP1893581B1 (fr) 2005-06-15 2010-01-27 Pfizer Limited Arylpyrazoles substitues pour une utilisation contre les parasites
US7645786B2 (en) 2005-06-15 2010-01-12 Pfizer Inc. Substituted arylpyrazoles
WO2006079999A2 (fr) * 2006-04-09 2006-08-03 Barth Frederik H Induction d'un nouvel etat psychique a l'aide d'un agoniste de 5-ht2a et d'un antagoniste de nmda
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
WO2010005507A1 (fr) 2008-06-30 2010-01-14 Afgin Pharma, Llc Traitement neuro-affectif régional topique
EP2149573A1 (fr) * 2008-08-01 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. Composé de sulfamide d'indole substituée, leur préparation et utilisation en tant que médicament
IT1393700B1 (it) * 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011004391A2 (fr) 2009-06-25 2011-01-13 Matrix Laboratories Ltd Procédé amélioré d'élaboration d'élétriptane et son sel correspondant
WO2011024039A1 (fr) * 2009-08-25 2011-03-03 Ramesh Babu Potluri Synthèse de nouveaux dérivés 5-(2-(phénylsulfonyl)éthyl)-1h-indole
WO2011089614A1 (fr) * 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited Procédé de préparation de bromhydrate d'élétriptan ayant une forme α
CN102606426B (zh) * 2012-03-02 2014-05-21 王仲彦 踏步健身发电装置
WO2014063752A1 (fr) 2012-10-26 2014-05-01 Synthon Bv Procédé de production de la forme cristalline alpha du bromhydrure d'élétriptan
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN103408535B (zh) * 2013-08-13 2016-03-02 张家港威胜生物医药有限公司 一种依来曲普坦中间体-5-溴-3-(n-甲基吡咯啉-2-基甲基)-1h-吲哚合成工艺
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
JP2018507262A (ja) 2015-03-02 2018-03-15 アフギン ファーマ, エルエルシーAfgin Pharma, Llc カンナビノイドを用いた、局所局部的神経作用療法
JP2019502761A (ja) 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ ((r)−3−[(−1−メチルピロリジン−2−イル)メチル]−5−(2−フェニルスルホニルエチル)−1h−インドールを作製する方法
CN106065008B (zh) * 2016-06-16 2018-06-05 黑龙江中医药大学 一种具有改善睡眠作用的吲哚-2-酰胺类化合物及其应用
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene
TR201616365A1 (tr) 2016-11-14 2018-05-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deksketoprofen ve eletri̇ptanin oral farmasöti̇k kompozi̇syonlari
TR201619983A2 (tr) 2016-12-29 2018-07-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Di̇klofenak ve eletri̇ptanin farmasöti̇k formülasyonlari
KR102129947B1 (ko) 2018-06-08 2020-07-03 김종창 콘크리트 타설을 위한 입체형 와이어 메쉬
EP3766483A1 (fr) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Composition de poudre orodispersible comprenant un triptane
US20230346746A1 (en) 2020-01-22 2023-11-02 Technophage, Investigaçäo E Desenvolvimento Em Biotecnologia, S.A. Eletriptan hydrobromide for treatment of spinal cord injury and improvement of locomotor function
WO2023150547A2 (fr) * 2022-02-01 2023-08-10 Caamtech, Inc. Composés psychédéliques et leurs utilisations thérapeutiques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL74527C (fr) *
US2773875A (en) * 1952-03-28 1956-12-11 Hoffmann La Roche Indole derivatives and method for producing same
GB886684A (en) * 1957-09-17 1962-01-10 Upjohn Co Improvements in or relating to heterocyclic compounds and the manufacture thereof
GB851780A (en) * 1958-02-25 1960-10-19 Rhone Poulenc Sa New indole derivatives
US3037031A (en) * 1959-08-04 1962-05-29 Warner Lambert Pharmaceutical Derivatives of 3-(2-aminoalkyl)-5-indolol and process therefor
GB893707A (en) * 1960-03-01 1962-04-11 Roche Products Ltd Novel tryptamine derivatives and a process for the manufacture thereof
GB966562A (en) * 1961-04-06 1964-08-12 Parke Davis & Co Amine compounds and means of producing the same
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
US4803218A (en) * 1982-09-29 1989-02-07 Mcneilab, Inc. 3-aminoalkyl-1H-indole-5-urea and amide derivatives
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NO985607L (no) 1998-12-01
AU8950491A (en) 1992-05-20
JP2677777B2 (ja) 1997-11-17
WO1992006973A1 (fr) 1992-04-30
CA2091562C (fr) 2001-03-27
FI931667A (fi) 1993-04-14
DE69127468D1 (de) 1997-10-02
NO2001019I1 (no) 2001-12-03
RO111767B1 (ro) 1997-01-30
YU48088B (sh) 1997-01-08
ZA918156B (en) 1993-04-14
BR9106978A (pt) 1993-09-28
BG61975B1 (bg) 1998-11-30
PT99218A (pt) 1992-09-30
DE10299004I1 (de) 2002-05-08
NZ270675A (en) 1997-07-27
IL99701A (en) 1996-10-31
SG54270A1 (en) 1998-11-16
DK0592438T3 (da) 1997-09-29
NO931378L (no) 1993-04-14
DE10299004I2 (de) 2006-03-16
PL168919B1 (pl) 1996-05-31
AU651637B2 (en) 1994-07-28
NO305121B1 (no) 1999-04-06
HUT64326A (en) 1993-12-28
NL300070I2 (nl) 2002-03-01
PT99218B (pt) 1999-04-30
IL115117A0 (en) 1995-12-08
MX9101606A (es) 1992-06-05
CN1062529A (zh) 1992-07-08
BG97632A (bg) 1994-03-31
CA2091562A1 (fr) 1992-04-16
EP0592438B1 (fr) 1997-08-27
DK0592438T5 (da) 1999-12-06
KR0179053B1 (ko) 1999-03-20
JPH05507288A (ja) 1993-10-21
CN1039322C (zh) 1998-07-29
NO931378D0 (no) 1993-04-14
NZ240217A (en) 1995-05-26
DE69127468T2 (de) 1998-01-02
MY111683A (en) 2000-11-30
ATE157361T1 (de) 1997-09-15
EP0592438A1 (fr) 1994-04-20
YU165391A (sh) 1994-01-20
BR1100080A (pt) 2000-06-06
LU90902I2 (fr) 2002-06-26
IL99701A0 (en) 1992-08-18
DE9190141U1 (de) 1993-07-15
JP2575272B2 (ja) 1997-01-22
NL300070I1 (nl) 2002-02-01
HU225055B1 (en) 2006-05-29
IL115117A (en) 1996-11-14
IE913555A1 (en) 1992-04-22
PL169987B1 (en) 1996-09-30
PL170330B1 (pl) 1996-11-29
JPH093063A (ja) 1997-01-07
EG20224A (en) 1997-12-31
OA09874A (en) 1994-09-15
ES2104733T3 (es) 1997-10-16
NO985607D0 (no) 1998-12-01
FI931667A0 (fi) 1993-04-14
GR3025087T3 (en) 1998-01-30
RU2095360C1 (ru) 1997-11-10
HU9301098D0 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
FI105812B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
US5545644A (en) Indole derivatives
US5578612A (en) Indole derivatives
KR100857671B1 (ko) 화학적 화합물
US5607951A (en) Indole derivatives
FI107158B (fi) Menetelmä kondensoitujen indolikarboksylaatti- ja indolikarboksiamidijohdannaisten valmistamiseksi
HU208132B (en) Process for producing 3-arylcarbonyl-1h-indole derivatives and pharmaceutical compositions comprising same
WO2014002052A1 (fr) Dérivés pyrrolidine et leur utilisation en tant que modulateurs de la voie du complément
ZA200603181B (en) 3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety
US20040157818A1 (en) Cxcr4-antagonistic drugs composed of nitrogen-containing compound
US5559129A (en) Indole derivatives
KR0183396B1 (ko) 3-아릴카르보닐-1-아미노알킬-1h-인돌류,이를 함유하는 항녹내장 조성물 및 이의 제조방법
TW199860B (fr)
US5559246A (en) Indole derivatives
US5319096A (en) (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
JP6844822B2 (ja) 疼痛に対して活性を有する置換モルホリン誘導体
JP6884973B2 (ja) 疼痛に対して活性を有するオキサジアザスピロ化合物
EP0906308A1 (fr) Derives de l'azetidine, de la pyrrolidine et de la piperidine utilises comme agonistes des recepteurs 5-ht1d
CA2350089C (fr) Derives d'indole
NZ612899B2 (en) Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L191

Extension date: 20151213

MA Patent expired